Published in Liver on June 01, 1999
An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87
Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J Gastroenterol (2014) 1.06
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int (2008) 1.04
A comparison of hepatopathologists' and community pathologists' review of liver biopsy specimens from patients with hepatitis C. Clin Gastroenterol Hepatol (2008) 1.02
Assessing liver fibrosis with serum marker models. Clin Biochem Rev (2007) 1.02
Design and validation of the biliary atresia research consortium histologic assessment system for cholestasis in infancy. Clin Gastroenterol Hepatol (2011) 0.96
Liver biopsy for histological assessment: The case against. Saudi J Gastroenterol (2010) 0.94
MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma. Biomed Res Int (2014) 0.94
Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B. Korean J Radiol (2016) 0.91
Feasibility of histological grading and staging of chronic viral hepatitis using specimens obtained by thin-needle biopsy. Virchows Arch (2003) 0.91
Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. J Clin Microbiol (2002) 0.85
A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation. Virol J (2011) 0.85
Digital analysis of hepatic sections in mice accurately quantitates triglycerides and selected properties of lipid droplets. Exp Biol Med (Maywood) (2010) 0.85
A new metabolism-related index correlates with the degree of liver fibrosis in hepatitis C virus-positive patients. Gastroenterol Res Pract (2015) 0.84
Checkmate to liver biopsy in chronic hepatitis C? World J Gastroenterol (2012) 0.84
Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis B. Gut Liver (2016) 0.81
Automated biphasic morphological assessment of hepatitis B-related liver fibrosis using second harmonic generation microscopy. Sci Rep (2015) 0.81
Histopathological Study of Chronic Hepatitis B: A Comparative Study of Ishak and METAVIR Scoring Systems. Int J Organ Transplant Med (2010) 0.79
A comparative evaluation of scoring systems for assessing necro-inflammatory activity and fibrosis in liver biopsies of patients with chronic viral hepatitis. J Clin Diagn Res (2014) 0.79
Reproducibility of liver biopsy grading and staging. Liver (1999) 0.78
Extent of liver inflammation in predicting response to interferon α & Ribavirin in chronic hepatitis C patients: a cohort study. BMC Gastroenterol (2012) 0.76
Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease. PLoS One (2016) 0.76
Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study. Medicine (Baltimore) (2017) 0.75
Clinical Utility of Biomarkers of Liver Fibrosis. Gastroenterol Hepatol (N Y) (2006) 0.75
Alleviative effects from boswellic acid on acetaminophen-induced hepatic injury. Biomedicine (Taipei) (2016) 0.75
Interobserver Agreement Using Histological Scoring of the Canine Liver. J Vet Intern Med (2017) 0.75
Prematurity and biliary atresia: a 30-year observational study. Pediatr Surg Int (2017) 0.75
Retracted Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet (1998) 36.93
Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group. Lancet (1998) 14.31
Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet (1989) 5.70
Hepatocytes from non-hepatic adult stem cells. Nature (2000) 3.27
Granulomatous vasculitis in Crohn's disease. Gastroenterology (1991) 2.72
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53
The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group. N Engl J Med (1990) 2.46
PGP 9.5--a new marker for vertebrate neurons and neuroendocrine cells. Brain Res (1983) 2.41
Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol (1996) 2.02
PGP 9.5, a new marker for human neuroendocrine tumours. Histopathology (1985) 1.97
Epidemiological aspects of Campylobacter jejuni enteritis. J Hyg (Lond) (1982) 1.95
An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87
Campylobacter jejuni enteritis transmitted from cat to man. Lancet (1980) 1.85
Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis (1999) 1.84
Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol (1993) 1.84
Evidence of persistent measles virus infection in Crohn's disease. J Med Virol (1993) 1.76
QBEnd/10: a new immunostain for the routine diagnosis of Kaposi's sarcoma. J Pathol (1990) 1.76
Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. J Virol Methods (1998) 1.73
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol (1996) 1.73
High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks. Hepatology (1994) 1.71
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut (1988) 1.67
The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br J Exp Pathol (1988) 1.67
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res (1995) 1.58
Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies. Br J Dermatol (2014) 1.57
Hepatocellular carcinoma arising in an adenoma: value of QBend 10 immunostaining in diagnosis of liver cell carcinoma. Histopathology (1996) 1.49
Small hepatocellular carcinomas in cirrhotic explant livers: identification by macroscopic examination and lipiodol localization. Hepatology (1997) 1.48
Genomic heterogeneity in synchronous hepatocellular carcinomas. Gut (1999) 1.44
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat (2000) 1.43
Review article: the pharmacological implications of leucocyte-endothelial cell interactions in Crohn's disease. Aliment Pharmacol Ther (1991) 1.40
Vascular invasion and herniation by hepatocellular carcinoma in cirrhosis: A wolf in sheep's clothing? Arch Pathol Lab Med (2005) 1.39
HIV-1 RNA is not detectable in the cerebrospinal fluid during antiretroviral combination therapy. AIDS (1997) 1.39
Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol (2007) 1.33
Neurone specific enolase: an aid to the diagnosis of melanoma and neuroblastoma. Histopathology (1982) 1.27
Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications. J Med Virol (1994) 1.26
V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology (1993) 1.24
Mother-to-infant transmission of hepatitis C virus. Ann Intern Med (1992) 1.23
Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepat (2002) 1.22
Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon. J Hepatol (1999) 1.21
The value of rectal biopsy in distinguishing self-limited colitis from early inflammatory bowel disease. Q J Med (1987) 1.18
Cerebrospinal fluid neopterin concentrations in central nervous system infection. J Infect Dis (1993) 1.17
Early mucosal changes in Crohn's disease. Gut (1993) 1.16
Immune activation and decreased tryptophan in patients with HIV-1 infection. J Interferon Res (1990) 1.15
Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy. Eur J Surg Oncol (2009) 1.12
Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment. Hepatology (1995) 1.11
Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy. Gut (1995) 1.10
IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1. J Viral Hepat (2011) 1.10
The epidemiological pattern of hepatitis A, B, and non-A, non-B in Sweden. Scand J Gastroenterol (1978) 1.10
Epidermal growth factor receptor expression and activation in neuroendocrine tumours. J Neuroendocrinol (2006) 1.09
Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1. AIDS (1989) 1.08
Mother to infant transmission of hepatitis C virus infection. J Med Virol (1990) 1.08
Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. J Virol (1994) 1.07
Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment Pharmacol Ther (1994) 1.07
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection. J Viral Hepat (2007) 1.07
Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microbiol (1992) 1.06
Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage. Hepatology (1996) 1.05
Clinical, epidemiological and prognostic aspects of hepatitis A, B and "non-A, non-B". Scand J Infect Dis Suppl (1978) 1.05
Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival. Eur J Surg Oncol (2002) 1.05
Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology (1995) 1.05
Immunohistochemical staining of granular cell tumour for neurone specific enolase: evidence in support of a neural origin. Diagn Histopathol (1983) 1.04
Pernicious anaemia and mucosal endocrine cell proliferation of the non-antral stomach. Gut (1986) 1.02
Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut (1996) 1.01
Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment. J Clin Microbiol (1995) 1.01
Guillain-Barré syndrome as an early manifestation of HIV central nervous system infection. Scand J Infect Dis (1986) 1.01
Expression of the mucosal vascular addressin, MAdCAM-1, in inflammatory liver disease. Liver (1999) 1.00
A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin. Aliment Pharmacol Ther (2002) 1.00
Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody. Clin Cancer Res (2000) 1.00
Early histological features of small intestinal injury induced by indomethacin. Aliment Pharmacol Ther (1993) 1.00
Evaluation of QuickVue, a rapid enzyme immunoassay test for the detection of serum antibodies to Helicobacter pylori. Diagn Microbiol Infect Dis (1993) 1.00
Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin. Gut (1997) 0.99
Neural markers in carcinoma of the lung. Br J Cancer (1985) 0.98
Mutation of nucleotide 1,762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriers. J Med Virol (1998) 0.98
Immunohistochemical studies of S100 protein and other neural characteristics expressed by granular cell tumour. Diagn Histopathol (1983) 0.98
Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity. Am J Pathol (1997) 0.97
In situ immune responses in Crohn's disease: a comparison with acute and persistent measles virus infection. J Med Virol (1997) 0.97
Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up. Transplantation (2000) 0.96
e antigen in acute hepatitis B. Br Med J (1976) 0.96
Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology (1993) 0.96
Contact tracing for human immunodeficiency virus (HIV) infection. Sex Transm Dis (1990) 0.96
Safety and effectiveness of 100 mg/kg/day deferiprone in patients with thalassemia major: a two-year study. Acta Haematol (2005) 0.95
Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C. Scand J Infect Dis (1998) 0.95
Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study. Scand J Infect Dis (1994) 0.95
Pre-ulcerative villous contraction and microvascular occlusion induced by indomethacin in the rat jejunum: a detailed morphological study. Aliment Pharmacol Ther (1995) 0.94
Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease. J Clin Pathol (1993) 0.94
The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine. J Infect Dis (1997) 0.94
Hepatitis E virus infections in patients with acute hepatitis non-A-D in Sweden. Scand J Infect Dis (1995) 0.93
Neurosecretory cells of the lamina propria of the appendix and their possible relationship to carcinoids. Histopathology (1982) 0.93